0001567619-18-001512.txt : 20180820
0001567619-18-001512.hdr.sgml : 20180820
20180820214602
ACCESSION NUMBER: 0001567619-18-001512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180816
FILED AS OF DATE: 20180820
DATE AS OF CHANGE: 20180820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOYLE JOHN C
CENTRAL INDEX KEY: 0001278454
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36330
FILM NUMBER: 181029416
MAIL ADDRESS:
STREET 1: 2 CORPORATE DR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLIGHT HEALTH, INC.
CENTRAL INDEX KEY: 0001433714
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
IRS NUMBER: 261989091
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SPEAR STREET
STREET 2: SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-671-4683
MAIL ADDRESS:
STREET 1: 150 SPEAR STREET
STREET 2: SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: VENTANA HEALTH SERVICES, INC.
DATE OF NAME CHANGE: 20090831
FORMER COMPANY:
FORMER CONFORMED NAME: MARIA HEALTH INC
DATE OF NAME CHANGE: 20080429
4
1
doc1.xml
FORM 4
X0306
4
2018-08-16
0
0001433714
CASTLIGHT HEALTH, INC.
CSLT
0001278454
DOYLE JOHN C
C/O CASTLIGHT HEALTH, INC.
150 SPEAR ST., SUITE 400
SAN FRANCISCO
CA
94105
1
1
0
0
Chief Executive Officer
Class B Common Stock
2018-08-16
4
M
0
7813
0
A
207876
D
Class B Common Stock
2018-08-16
4
M
0
18750
0
A
226626
D
Class B Common Stock
2018-08-16
4
M
0
23750
0
A
250376
D
Class B Common Stock
2018-08-17
4
S
0
19024
2.6986
D
231352
D
Restricted Stock Units
0
2018-08-16
4
M
0
7813
0
D
Class B Common Stock
7813
46875
D
Restricted Stock Units
0
2018-08-16
4
M
0
18750
0
D
Class B Common Stock
18750
150000
D
Restricted Stock Units
0
2018-08-16
4
M
0
23750
0
D
Class B Common Stock
23750
332500
D
Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4.
Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
Represents the weighted average sales price per share. The shares sold at prices ranging from $2.675 to $2.825 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
/s/ Jennifer Chaloemtiarana, by power of attorney
2018-08-20